DE69702580D1 - Hydrochinon-Derivate und deren pharmazeutische Verwendung - Google Patents

Hydrochinon-Derivate und deren pharmazeutische Verwendung

Info

Publication number
DE69702580D1
DE69702580D1 DE69702580T DE69702580T DE69702580D1 DE 69702580 D1 DE69702580 D1 DE 69702580D1 DE 69702580 T DE69702580 T DE 69702580T DE 69702580 T DE69702580 T DE 69702580T DE 69702580 D1 DE69702580 D1 DE 69702580D1
Authority
DE
Germany
Prior art keywords
group
hydrogen atom
alkyl group
oxo
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69702580T
Other languages
English (en)
Other versions
DE69702580T2 (de
Inventor
Yoshiaki Isobe
Yuso Goto
Masanori Tobe
Osamu Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Application granted granted Critical
Publication of DE69702580D1 publication Critical patent/DE69702580D1/de
Publication of DE69702580T2 publication Critical patent/DE69702580T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69702580T 1996-09-19 1997-09-17 Hydrochinon-Derivate und deren pharmazeutische Verwendung Expired - Fee Related DE69702580T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24827296 1996-09-19

Publications (2)

Publication Number Publication Date
DE69702580D1 true DE69702580D1 (de) 2000-08-24
DE69702580T2 DE69702580T2 (de) 2001-03-08

Family

ID=17175664

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69702580T Expired - Fee Related DE69702580T2 (de) 1996-09-19 1997-09-17 Hydrochinon-Derivate und deren pharmazeutische Verwendung

Country Status (13)

Country Link
US (2) US5821247A (de)
EP (1) EP0831092B1 (de)
AT (1) ATE194838T1 (de)
AU (1) AU716992B2 (de)
CA (1) CA2216288C (de)
DE (1) DE69702580T2 (de)
DK (1) DK0831092T3 (de)
ES (1) ES2149548T3 (de)
GR (1) GR3034418T3 (de)
NO (1) NO313413B1 (de)
NZ (1) NZ328769A (de)
PT (1) PT831092E (de)
ZA (1) ZA978413B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ519781A (en) * 1999-12-23 2004-04-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
JPWO2004026842A1 (ja) * 2002-09-20 2006-01-12 住友製薬株式会社 新規ウラシル誘導体及びその医薬用途
CA2704473C (en) 2007-11-06 2016-10-04 Edison Pharmaceuticals, Inc. 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
ES2912585T3 (es) 2014-12-16 2022-05-26 Ptc Therapeutics Inc Formas polimórficas y amorfas de la (R)-2-hidroxi-2-metil-4-(2,4,5-trimetil-3,6-dioxociclohexa-1,4-dienil)butanamida
WO2017060432A1 (en) * 2015-10-08 2017-04-13 Khondrion Ip B.V. Novel compounds for treating mitochondrial disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof

Also Published As

Publication number Publication date
EP0831092B1 (de) 2000-07-19
NZ328769A (en) 1998-07-28
DK0831092T3 (da) 2000-10-16
NO313413B1 (no) 2002-09-30
ES2149548T3 (es) 2000-11-01
DE69702580T2 (de) 2001-03-08
NO974313D0 (no) 1997-09-18
ZA978413B (en) 1998-03-26
NO974313L (no) 1998-03-20
CA2216288A1 (en) 1998-03-19
AU3760197A (en) 1998-03-26
CA2216288C (en) 2006-02-07
US5821247A (en) 1998-10-13
US5877318A (en) 1999-03-02
EP0831092A2 (de) 1998-03-25
AU716992B2 (en) 2000-03-16
PT831092E (pt) 2000-10-31
GR3034418T3 (en) 2000-12-29
ATE194838T1 (de) 2000-08-15
EP0831092A3 (de) 1998-04-08

Similar Documents

Publication Publication Date Title
CA2234096A1 (en) 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
DE69533277D1 (de) Dc-89 derivat
EP0955293A4 (de) Neue harnstoffderivate
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
ATE218345T1 (de) Arzneimittel gegen spinocerebellare degeneration
CA2219675A1 (en) Pentacyclic compound
EA200200119A1 (ru) β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
EP0292576A4 (en) Anti-ulcerous agent containing chalcone derivative as effective ingredient and novel chalcone derivatives
DE69702580D1 (de) Hydrochinon-Derivate und deren pharmazeutische Verwendung
DE69122812D1 (de) Glutathionderivat
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
CA2262997A1 (en) Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
ATE219065T1 (de) Arylpiperidin- und arylpiperazin-derivate und sie enthaltende arzneimittel
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
FR2778404B1 (fr) Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
ES2151442B1 (es) Nuevo derivado del bencenoetanol.
BG102429A (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means
RS50791B (sr) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
DK378087D0 (da) Tetracycliske indolderivater
EP1048649A4 (de) 5-arylpyrrol-derivate
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
ATE117682T1 (de) Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen.
EP0887351A4 (de) Dc 107-derivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee